Joon Soo An

Dr. Joon Soo An

Seoul National University, Seoul, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2023 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
HNHyunsung Nam
Hyunsung Nam
JAJoon Soo An
Joon Soo An
JLJaepil Lee
Jaepil Lee
YYYonghwan Yun
Yonghwan Yun
HLHyunbin Lee
Hyunbin Lee
SKSeokhee Kim
Seokhee Kim

12 May 2023 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
JAJoon Soo An
Joon Soo An
HLHyunbin Lee
Hyunbin Lee
HKHyungyu Kim
Hyungyu Kim
SWSeungyeon Woo
Seungyeon Woo
HNHyunsung Nam
Hyunsung Nam
DODong-Chan Oh
Dong-Chan Oh

16 March 2022 in Journal of Natural Products
Verified
Journal Article
Closed access
JAJoon Soo An
Joon Soo An
MKMyoun-Su Kim
Myoun-Su Kim
JHJaeho Han
Jaeho Han
SJSung Chul Jang
Sung Chul Jang
JIJi Hyeon Im
Ji Hyeon Im
DODong-Chan Oh
Dong-Chan Oh

29 August 2023 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
DSDaniel Shin
Daniel Shin
WBWoong Sub Byun
Woong Sub Byun
SKSangwook Kang
Sangwook Kang
IKIlnam Kang
Ilnam Kang
EBEun Seo Bae
Eun Seo Bae
DODong-Chan Oh
Dong-Chan Oh

12 July 2022 in Marine Drugs
Verified
Journal Article
Open access
PDF file
SKSangwook Kang
Sangwook Kang
JHJaeho Han
Jaeho Han
SJSung Chul Jang
Sung Chul Jang
JAJoon Soo An
Joon Soo An
IKIlnam Kang
Ilnam Kang
DODong-Chan Oh
Dong-Chan Oh
Cinnamoyl-containing nonribosomal peptides (CCNPs) form a unique family of actinobacterial secondary metabolites and display various biological activities. A new CCNP named epoxinnamide (1) was discovered from intertidal mudflat-derived Streptomyces sp. OID44. The structure of 1 was determined by the analysis of one-dimensional (1D) and two-dimensional (2D) nuclear magnetic resonance (NMR) data along with a mass spectrum. The absolute configuration of 1 was assigned by the combination of advanced Marfey’s method, 3JHH and rotating-frame overhauser effect spectroscopy (ROESY) analysis, DP4 calculation, and genomic analysis. The putative biosynthetic pathway of epoxinnamide (1) was identified through the whole-genome sequencing of Streptomyces sp. OID44. In particular, the thioesterase domain in the nonribosomal peptide synthetase (NRPS) biosynthetic gene cluster was proposed as a bifunctional enzyme, which catalyzes both epimerization and macrocyclization. Epoxinnamide (1) induced quinone reductase (QR) activity in murine Hepa-1c1c7 cells by 1.6-fold at 5 μM. It also exhibited effective antiangiogenesis activity in human umbilical vein endothelial cells (IC50 = 13.4 μM).

18 February 2020 in Marine Drugs
Verified
Journal Article
Open access
PDF file
MBMunhyung Bae
Munhyung Bae
JAJoon Soo An
Joon Soo An
SHSeong-Heon Hong
Seong-Heon Hong
EBEun Seo Bae
Eun Seo Bae
BCBEOMKOO CHUNG
BEOMKOO CHUNG
DODong-Chan Oh
Dong-Chan Oh
Chemical profiling of the Streptomyces sp. strain SUD119, which was isolated from a marine sediment sample collected from a volcanic island in Korea, led to the discovery of three new metabolites: donghaecyclinones A–C (1–3). The structures of 1–3 were found to be rearranged, multicyclic, angucyclinone-class compounds according to nuclear magnetic resonance (NMR) and mass spectrometry (MS) analyses. The configurations of their stereogenic centers were successfully assigned using a combination of quantum mechanics–based computational methods for calculating the NMR shielding tensor (DP4 and CP3) as well as electronic circular dichroism (ECD) along with a modified version of Mosher’s method. Donghaecyclinones A–C (1–3) displayed cytotoxicity against diverse human cancer cell lines (IC50: 6.7–9.6 μM for 3).